Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee

Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond

“…Recent research has suggested that the risk of Rh sensitization after early abortion is negligible [34][35][36]. Consequently, the National Abortion Federation has concluded that forgoing Rh typing and administration of anti-D immunoglobulin is reasonable for Rh-negative patients having aspiration abortion before 56 days of gestation and may be considered for all patients having MA at less than 70 days [16,37]. The sample protocol is consistent with this conclusion.…”

Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic

“…The American College of Obstetricians and Gynecologists and other professional organizations quickly endorsed telehealth and no-test abortion care. 1 These protocols omit Rh testing 2 and use patient history, rather than routine ultrasonography, to assess pregnancy duration and screen for ectopic pregnancy risks. 3 , 4 …”

Anti-D prophylaxis for rhesus D (RhD)-negative women having an abortion of a pregnancy up to 13+6weeks’ gestation: a systematic review and new NICE consensus guidelines

“…Epidemiological data comparing isoimmunisation rates in the Netherlands, where anti-D is not given to miscarriages under 10 weeks or abortions under 7 weeks, with Canada where anti-D is routinely administered showed that the prevalence of clinically significant antibodies was lower in the Netherlands 18. The American National Abortion Federation has recently recommended not testing or administering anti-D for any abortion under 8 weeks, and to consider not doing so for medical abortions under 10 weeks 19…”